Novavax Analyst Price Targets - Benzinga

Novavax Inc

NVAXNASDAQ

Trade with Public

Trade with Public

$10.22

-0.12-1.16%

At close: Sep 4, 5:00 PM EST

$10.20

-0.02-0.2%

After Hours: Sep 4, 7:58 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Novavax Analyst Price Targets

Wall Street analyst price targets and consensus rating for Novavax (NVAX).

Price Target Range — 10 Quarters

Analyst Consensus — 9 Analysts

5Buy

1Hold

3Sell

Consensus RatingBuy# Analysts9Avg. Consensus PT$13Upside to Avg. PT+26.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jun 11, 2026	BTIG	Thomas Shrader	Maintained	Buy	$19
May 6, 2026	TD Cowen	Chris LoBianco	PT Raise	Hold	$8→$9
Feb 27, 2026	HC Wainwright & Co.	Sean Lee	PT Raise	Buy	$11→$16
Jan 20, 2026	BTIG	Thomas Shrader	Maintained	Buy	$19
Nov 18, 2025	JP Morgan	Anupam Rama	PT Cut	Underweight	$7→$6
Nov 10, 2025	B. Riley Securities	Mayank Mamtani	PT Cut	Buy	$18→$16
Nov 4, 2025	TD Cowen	Brendan Smith	PT Cut	Hold	$8→$7
Oct 24, 2025	Cantor Fitzgerald	Pete Stavropoulos	Initiate	Overweight	$18
Oct 23, 2025	HC Wainwright & Co.	Sean Lee	PT Raise	Buy	$10→$11
Aug 28, 2025	HC Wainwright & Co.	Sean Lee	Assumes	Buy	$10
Aug 20, 2025	B of A Securities	Alec Stranahan	Downgrade	Neutral→Underperform	$9→$7
Jul 22, 2025	B of A Securities	Alec Stranahan	PT Cut	Neutral	$10→$9
Jun 17, 2025	Citigroup	Geoff Meacham	Initiate	Sell	$6
May 9, 2025	JP Morgan	Eric Joseph	PT Cut	Underweight	$9→$7
Dec 10, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Nov 13, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Nov 12, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$19
Oct 16, 2024	Jefferies	Roger Song	PT Cut	Buy	$31→$25
Oct 10, 2024	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$23→$26
Oct 2, 2024	Jefferies	Roger Song	Maintained	Buy	$31

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Hold on Novavax, Raises Price Target to $9

TD Cowen analyst Chris LoBianco maintains Novavax (NASDAQ:NVAX) with a Hold and raises the price target from $8 to $9.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $16

HC Wainwright & Co. analyst Sean Lee maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $11 to $16.

Benzinga Newsdesk

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Avi Kapoor

PRO
B. Riley Securities Reiterates Buy on Novavax, Lowers Price Target to $16

B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $18 to $16.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on Novavax, Lowers Price Target to $7

TD Cowen analyst Brendan Smith maintains Novavax (NASDAQ:NVAX) with a Hold and lowers the price target from $8 to $7.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Initiates Coverage On Novavax with Overweight Rating, Announces Price Target of $18

Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Novavax (NASDAQ:NVAX) with a Overweight rating and announces Price Target of $18.

Benzinga Newsdesk